在东亚人群中,T2DM可能对消化系统瘤产生保护作用:孟德尔的随机化分析
Ni An1, Yu Zhang2, Zhilin Sha3
1Department of Anesthesiology, The Eighth Medical Center of Chinese PLA General Hospital, Beijing, China.
Frontiers in oncology
|July 1, 2024
概括
2型糖尿病 (T2DM) 与消化系统癌症有关. 虽然T2DM降低了食道,胃,结肠直肠和肝癌的风险,但它增加了胰腺癌的风险,部分原因是胰岛素和血红蛋白A1c水平的变化.
科学领域:
- 遗传学和流行病学
- 代谢障碍 代谢障碍 代谢障碍
- 在瘤学瘤学.
背景情况:
- 2型糖尿病 (T2DM) 是一个全球性的健康问题,与各种疾病有复杂的关联.
- 新出现的证据表明T2DM与消化系统瘤之间存在联系,但因果关系和潜在机制需要进一步阐明.
- 了解这些联系对于制定针对T2DM和消化道癌症的有针对性的预防和治疗策略至关重要.
研究的目的:
- 使用孟德尔随机化研究2型糖尿病和五种常见的消化系统瘤之间的因果关系.
- 探索糖尿病相关表型的潜在调解作用,如禁食胰岛素和糖化血红蛋白水平,在这些协会中.
- 提供有关T2DM与消化道癌症风险相关的生物机制的见解.
主要方法:
- 利用公开可用的全基因组关联研究 (GWAS) 数据.
- 采用孟德尔随机化 (MR) 分析,主要是逆方差加权 (IVW) 方法,以评估因果关系.
- 进行了灵敏度分析,包括埃格尔截取和MR-PRESSO测试,以检测型,异质性和留出一个的分析.
主要成果:
- 在东亚人群中,T2DM与食道,胃,结肠直肠癌和肝细胞癌的风险降低有关.
- 相反,T2DM显示胰腺癌的风险增加.
- 降低的禁食胰岛素水平部分介导了T2DM-食道癌链接,而增加的糖化血红蛋白水平与胰腺癌风险有关,反之则与胃癌风险有关.
结论:
- 在各种消化系统瘤上,T2DM表现出不同的因果作用,降低了一些人的风险,同时增加了其他人的风险.
- 已确定的禁食胰岛素和糖化血红蛋白的调解作用为T2DM对消化系统癌症发展的影响提供了机制性的见解.
- 这些发现突显了代谢健康和癌症病因学之间的复杂相互作用,特别是在东亚人口中.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.